Silence Therapeutics Plc (SLNCF)
5.50
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Silence Therapeutics Max Drawdown (5Y) : 98.33% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 98.33% |
| June 30, 2026 | 98.33% |
| May 31, 2026 | 98.33% |
| April 30, 2026 | 98.33% |
| March 31, 2026 | 98.33% |
| February 28, 2026 | 98.33% |
| January 31, 2026 | 98.33% |
| December 31, 2025 | 98.33% |
| November 30, 2025 | 98.33% |
| October 31, 2025 | 98.33% |
| September 30, 2025 | 98.33% |
| August 31, 2025 | 98.33% |
| July 31, 2025 | 98.33% |
| June 30, 2025 | 98.33% |
| May 31, 2025 | 98.33% |
| April 30, 2025 | 98.33% |
| March 31, 2025 | 97.99% |
| February 28, 2025 | 97.99% |
| January 31, 2025 | 97.99% |
| December 31, 2024 | 97.99% |
| November 30, 2024 | 97.99% |
| October 31, 2024 | 97.99% |
| September 30, 2024 | 97.99% |
| August 31, 2024 | 97.99% |
| July 31, 2024 | 97.99% |
| Date | Value |
|---|---|
| June 30, 2024 | 97.99% |
| May 31, 2024 | 97.99% |
| April 30, 2024 | 97.99% |
| March 31, 2024 | 97.99% |
| February 29, 2024 | 97.99% |
| January 31, 2024 | 97.99% |
| December 31, 2023 | 97.99% |
| November 30, 2023 | 97.99% |
| October 31, 2023 | 97.99% |
| September 30, 2023 | 97.99% |
| August 31, 2023 | 97.99% |
| July 31, 2023 | 97.15% |
| June 30, 2023 | 97.15% |
| May 31, 2023 | 95.58% |
| April 30, 2023 | 95.58% |
| March 31, 2023 | 95.58% |
| February 28, 2023 | 95.58% |
| January 31, 2023 | 95.58% |
| December 31, 2022 | 95.58% |
| November 30, 2022 | 95.58% |
| October 31, 2022 | 95.58% |
| September 30, 2022 | 91.12% |
| August 31, 2022 | 90.63% |
| July 31, 2022 | 90.63% |
| June 30, 2022 | 90.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biodexa Pharmaceuticals Plc | 100.0% |
| NuCana Plc | 99.99% |
| Mereo BioPharma Group Plc | 95.13% |
| Compass Pathways Plc | 96.03% |
| HemoGenyx Pharmaceuticals Plc | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.07 |
| Beta (5Y) | 0.4825 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 284.3% |
| Historical Sharpe Ratio (5Y) | -0.1148 |
| Historical Sortino (5Y) | -0.4387 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 55.09% |